Integrated Biotherapeutics LLC
Records under this name other than patents Integrated Biotherapeutics LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Integrated Biotherapeutics LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,109,036 | Immunogenic Composition Comprising Alpha-Hemolysin Oligopeptides now held by Abvacc, Inc. In force · High confidence | In force | High confidence | |
| US 10,023,848 | Immunogenic Composition Comprising Panton-Valentine Leukocidin (PVL) Derived Polypeptides now held by Abvacc, Inc. In force · High confidence | In force | High confidence | |
| US 9,815,872 | Toxoid Peptides Derived from Phenol Soluble Modulin, Delta Toxin, Superantigens, and Fusions Thereof now held by Abvacc, Inc. In force · High confidence | In force | High confidence | |
| US 10,174,085 | Toxoid Peptides Derived From Phenol Soluble Modulin, Delta Toxin, Superantigens, and Fusions Thereof now held by Abvacc, Inc. In force · High confidence | In force | High confidence | |
| US 11,028,153 | Targeting Immunological Functions to the Site of Bacterial Infections Using Cell Wall Targeting Domains of Bacteriolysins now held by Abvacc, Inc. In force · High confidence | In force | High confidence | |
| US 10,487,140 | Targeting Immunological Functions to the Site of Bacterial Infections Using Cell Wall Targeting Domains of Bacteriolysins now held by Abvacc, Inc. In force · High confidence | In force | High confidence | |
| US 10,611,827 | Non-Human Primate-Derived Pan-Ebola and Pan-Filovirus Monoclonal Antibodies Directed Against Envelope Glycoproteins now held by Razi Holdings, Inc. In force · High confidence | In force | High confidence | |
| US 11,186,626 | Broadly Neutralizing Antibody Targeting the Ebolavirus Glycoprotein Internal Fusion Loop now held by Razi Holdings, Inc. In force · High confidence | In force | High confidence | |
| US 11,421,021 | Immunogenic Compositions Comprising Staphylococcus Aureus Leukocidin Luka and Lukb Derived Polypeptides now held by Abvacc, Inc. In force · High confidence | In force | High confidence | |
| US 11,260,120 | Immunogenic Composition Comprising a Fusion Peptide Derived from Superantigen Toxoids now held by Abvacc, Inc. In force · High confidence | In force | High confidence |